Recent Updates
Recently added Catalysts

Health In Tech, Inc. Class A Common Stock

HITFDA catalysts, PDUFA dates & pipeline intelligence
$0.33
▼ -0.07 · -16.61%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full HIT financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.3152W HIGH $2.10
Volume
109.86 K
Value Traded
42.37 K
Short % Float
3.46%
Days to Cover
10.3
-44.45%Week
-48.07%1 Month
-67.02%3 Month
-67.35%6 Month

Cash Data

Unlock HIT cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
26.28 M
EPS (TTM)
-0.18
P/E Ratio
-
Ent. Value
16.15 M
Total Shares
79.69 M
Float Shares
17.40 M
Insiders
73.35%
Institutions
7.67%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every HIT catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

HIT Catalyst Timeline

Dated clinical, regulatory and corporate events for Health In Tech, Inc. Class A Common Stock

Unlock the full HIT catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How HIT actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all HIT historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Health In Tech, Inc. Class A is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every HIT program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every HIT trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock HIT insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Hasan Zain SyedOfficer (Chief Growth Officer)Sell -1,667 171,993 held$0.55 11/03/2026
Unlock the full HIT insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in HIT for Q3 2026.
Unlock every fund holding HIT
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in HIT
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see HIT ownership
Insider and institutional ownership, quarter by quarter.

HIT Short Interest

Shares sold short, counted twice a month.

3.46%
Short % of Float
of tradable shares sold short
602.4K
Shares Sold Short
+42.3% vs prior count
10.3 Very high
Days to Cover
trading days of normal volume to buy every short share back
58.3K
Avg Daily Volume
the average used for days to cover
Unlock HIT short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock HIT option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live HIT option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock HIT options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How HIT ranks across every disease it competes in

Competitive Position is a premium feature
See how HIT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

HIT News

-HIT
Nov 17, 2026
HITGeneral
▼ -16.6%today

Health In Tech Appoints Wall Street Research and Capital Markets Veteran Christina R. Valauri to Board of Directors

Health In Tech appointed Christina R. Valauri to its Board of Directors, effective November 12, 2026. Valauri brings over 30 years of experience in financial services, including senior roles at major firms. She will serve on multiple committees and is expected to provide valuable insights for the company's growth and governance.

Read more →
-HIT
Nov 12, 2026
HITGeneral
▼ -26.1%on this news· ran to -38% by day 1

Health In Tech Reports Third Quarter 2026 Financial Results

Health In Tech reported a net loss of $7.1 million for Q3 2026, down from a profit of $0.5 million in Q3 2025. Revenue for the quarter was $6.6 million, a decline from $8.5 million year-over-year. The company has expanded its distribution partners by 15.9% and has a pipeline revenue of $156.4 million as of October 30, 2026.

Read more →
-HIT
Oct 29, 2026
HITGeneral
▼ -5.9%on this news

Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026

Health In Tech, Inc. will announce its third quarter 2026 financial results on November 12, 2026. The company plans to host a conference call at 5:00 p.m. ET to discuss these results and its business outlook. The earnings call will be accessible via a live webcast and a replay will be available afterward.

Read more →
-HIT
Oct 26, 2026
HITGeneral
▲ +7.3%on this news· ran to +21% by day 1shared move

Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion

Health In Tech appointed Sanjay Shrestha as CEO, effective October 20, 2026, succeeding founder Tim Johnson, who becomes Executive Chairman. This leadership change aims to enhance commercial execution and pursue strategic acquisitions. Shrestha's experience in scaling businesses will be pivotal in advancing the company's growth and operational capabilities.

Read more →
-HIT
Oct 16, 2026
HITGeneral

Health In Tech to Host Annual Meeting of Stockholders

Health In Tech, Inc. will hold its 2026 Annual Meeting of Stockholders on November 10, 2026, at 10:00 AM ET via a live virtual webcast. Stockholders as of September 18, 2026, can vote electronically and submit questions during the meeting. Guests can listen in without a control number, and a replay will be available on the company's website.

Read more →
-HIT
Oct 8, 2026
HITGeneral

Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement

Health In Tech has launched HitRix, an AI-enabled platform designed to streamline the process of placing self-funded stop-loss health insurance. This broker-first marketplace allows brokers to manage submissions, compare quotes, and track cases from a single dashboard, significantly reducing operational inefficiencies. The platform aims to enhance decision-making and improve communication between brokers and market partners.

Read more →
-HIT
Oct 2, 2026
HITConferences/Events
▲ +6.2%on this news

Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference

Health In Tech, Inc. announced its participation in the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. The company's management will engage in one-on-one meetings with institutional investors at the event. Health In Tech aims to enhance processes in the health insurance sector through its AI-enabled InsurTech platform.

Read more →
-HIT
Sep 30, 2026
HITGeneral
▼ -10.1%on this newsshared move

Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance

Health In Tech, Inc. has launched HitRix, an AI-powered platform aimed at simplifying workflows in the self-funded health insurance market. The company also updated its revenue guidance for 2026 to approximately $33 million, aligning with 2025 figures. HitRix is expected to drive growth starting in 2027 as adoption increases and new initiatives take effect.

Read more →
-HIT
Sep 9, 2026
HITGeneral

Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026

Health In Tech, Inc. has been named one of Newsweek's America's Greatest Mid-Market Companies for 2026, ranking among the top 100 U.S. public mid-market companies. The recognition is based on a thorough evaluation of financial strength, workforce performance, innovation, and sustainability. CEO Tim Johnson highlighted the company's focus on AI-driven products and commitment to long-term sustainability.

Read more →
-HIT
Aug 13, 2026
HITGeneral
▼ -5.2%on this news

Health In Tech Reports Second Quarter 2026 Financial Results

Health In Tech, Inc. reported its financial results for Q2 2026, showing a net loss of $2.5 million and a decrease in revenue compared to the previous year. Despite these challenges, the company noted a 19.9% increase in distribution partners and a robust pipeline revenue of $66.3 million. The CEO highlighted ongoing investments in growth and reaffirmed the company's revenue guidance for the year.

Read more →
-HIT
Aug 3, 2026
HITGeneral

Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026

Health In Tech, Inc. will announce its second quarter 2026 financial results on August 13, 2026, following the market close. The company will host a conference call to discuss the results and its business outlook. This announcement corrects an earlier error regarding the date of the call.

Read more →
-HIT
Jun 29, 2026
HITGeneral

Health In Tech Added to Membership of Russell Microcap® Index

Health In Tech, Inc. has been added to the Russell Microcap Index, effective June 29, 2026. This inclusion is part of the Russell U.S. indexes reconstitution and signifies recognition of the company's advancements in the InsurTech sector. CEO Tim Johnson expressed optimism that this milestone will enhance the company's visibility among institutional investors.

Read more →
-HIT
May 13, 2026
HITConferences/Events

Q1 2026 Earnings Conference Call

The Health In Tech Q1 2026 earnings conference call highlighted the company's strategic focus on expanding sales distribution and technology enhancements. CEO Tim Johnson noted the substantial potential in the self-funded insurance market, where the company's current penetration remains low. A recent $7 million PIPE investment will support initiatives to grow their distribution network and improve technological capabilities. The call also included forward-looking statements regarding the business's growth outlook and market strategies.

Read more →
-HIT
May 13, 2026
HITGeneral

Health In Tech Reports First Quarter 2026 Financial Results

Health In Tech, Inc. reported a 9.4% increase in revenue for Q1 2026, totaling $8.8 million. However, the company faced a net loss of $1.6 million, contrasting with a profit in the same quarter last year. The firm reiterated its revenue guidance for 2026, projecting between $45 million and $50 million, driven by growth in distribution partners and new product features.

Read more →
-HIT
May 13, 2026
HITGeneral

An AI - Powered Marketplace Platform Helping SMBs Access Better Self - Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT,"

Health In Tech, Inc. has launched an AI-powered marketplace platform aimed at helping small and medium-sized businesses (SMBs) access improved self-funded health plans. The platform seeks to address the complexities that have historically limited SMBs from leveraging these plans, thus providing greater flexibility and cost benefits. Furthermore, HIT aims to streamline health plan administration and underwriting through its integrated system, facilitating quicker onboarding for employer groups. This innovative approach could disrupt the current landscape of healthcare insurance and enhance accessibility for smaller businesses.

Read more →
-HIT
Apr 21, 2026
HITConferences/Events

Health In Tech to Present at the Market Movers Investor Summit

Health In Tech, Inc. will present at the Market Movers Investor Summit on May 5, 2026. The event is recognized as a premier Wall Street gathering, featuring company presentations and networking opportunities. Julia Qian, CFO of Health In Tech, will lead the company's presentation at 3:00 PM ET at the historic Bank of New York.

Read more →
-HIT
Apr 20, 2026
HITGeneral
▲ +5.6%on this news· ran to +21% by day 1shared move

Health In Tech Announces Zain Hasan as Chief Growth Officer to Accelerate Revenue Growth and Scale Distribution

Health In Tech has appointed Zain Hasan as Chief Growth Officer to lead its growth strategy. Hasan, who joined the company in September 2025, will focus on revenue generation and performance across various sectors. The company is optimistic about entering a high-growth phase, leveraging its AI-enabled platform to enhance its offerings.

Read more →
-HIT
Apr 20, 2026
HITGeneral

Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth

Health In Tech has appointed Sri Rajagopalan as Chief Technology Officer, effective February 23, 2026. Rajagopalan, who previously served as Interim CTO, will lead the company's technology strategy, focusing on AI development and platform modernization. His extensive experience in enterprise architecture and healthcare technology is expected to enhance the company's operational capabilities and support future growth initiatives.

Read more →
-HIT
Apr 20, 2026
HITConferences/Events

Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

Health In Tech, Inc. will announce its fourth quarter and full year 2025 financial results on March 25, 2026. The announcement includes a conference call to discuss the results and business outlook. This event highlights the company's commitment to transparency and investor engagement.

Read more →
-HIT
Apr 20, 2026
HITGeneral

Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech Platform

Health In Tech, Inc. has announced a strategic collaboration with Ciklum to enhance its AI-driven InsurTech platform. This partnership aims to optimize administrative, sales, and analytics capabilities, leveraging Ciklum's expertise in AWS architecture and AI software development. The collaboration is expected to improve platform usability and expand market reach for Health In Tech.

Read more →

About Health In Tech, Inc. Class A Common Stock

Stuart, FL 91 employees healthintech.com
Headquarters701 S. COLORADO AVE, STUART, FL, 34994
BIOPHARMAWATCH ELITE
Trade the next HIT catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime